These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7466746)

  • 1. Activity of antithrombin III and effect of heparin on coagulation in shock.
    Blauhut B; Necek S; Kramar H; Vinazzer H; Bergmann H
    Thromb Res; 1980 Sep; 19(6):775-82. PubMed ID: 7466746
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of DIC with antithrombin III concentrates.
    Sakata Y; Yoshida N; Matsuda M; Aoki N
    Bibl Haematol; 1983; (49):307-16. PubMed ID: 6667252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of heparin therapy in Dispholidus typus envenomation: an experimental study.
    Atkinson PM; Rebello M; Gaillard MC; Bradlow BA
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):355-63. PubMed ID: 6798704
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
    Bounameaux H; Marbet GA; Lämmle B; Eichlisberger R; Duckert F
    Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits.
    Tazawa S; Ichikawa K; Misawa K; Fukuyama J; Hamano S; Miyata H; Sakuragawa N
    Thromb Res; 1995 Dec; 80(5):391-8. PubMed ID: 8588200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases.
    Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M
    Jpn J Clin Oncol; 1985 Sep; 15(3):483-8. PubMed ID: 4057631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution therapy with an antithrombin III concentrate in shock and DIC.
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Thromb Res; 1982 Aug; 27(3):271-8. PubMed ID: 7135359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation parameters and heparin levels in open-heart surgery.
    Cullmann W; Müller N; Lie TB; Kladetzky RG; Jürgens P
    Res Exp Med (Berl); 1980; 177(2):111-7. PubMed ID: 7444168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.
    Soulier JP; Gozin D; Lerable J
    Thromb Res; 1984 May; 34(3):255-62. PubMed ID: 6729779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated intravascular coagulation: a clinical/laboratory study of 48 patients.
    Bick RL
    Ann N Y Acad Sci; 1981; 370():843-50. PubMed ID: 6943979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of heparin resistance and their clinical significance].
    Barkagan ZS; Lychev VG; Bishevskiĭ KM; Tsyvkina LP; Glazunova GA
    Ter Arkh; 1982; 54(8):77-82. PubMed ID: 6753220
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.